XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Breast Channel
subscribe to Breast newsletter

Latest Research : Cancer : Breast

   DISCUSS   |   EMAIL   |   PRINT
Study examines impact of two-year screening interval for breast cancer
Dec 16, 2004, 19:31, Reviewed by: Dr.



 
Except for women in their 40s, women who are screened with mammography every 2 years may not have an increased risk of late-stage breast cancer compared with women screened every year, according to a new study in the December 15 issue of the Journal of the National Cancer Institute.

The ideal interval between screenings for breast cancer using mammography has not been determined. In the United States, the U.S. Preventive Services Task Force recommends screening with mammography every 1 to 2 years, whereas the American Cancer Society recommends annual screening. In Europe, most countries recommend that women be screened every 2 years and concentrate their recommendations on women age 50 and older.

To determine if women screened every 2 years have an increased risk of late-stage breast cancer, Emily White, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted an observational study using data collected by seven mammography registries in the United States. They examined whether the 2,440 women who had been diagnosed with breast cancer after receiving biennial screening were more likely to have been diagnosed with late-stage cancer compared with 5,400 women diagnosed with breast cancer after receiving annual screening.

Among women age 50 years or older, there was no increase in the risk of late-stage breast cancer for those who received screening every 2 years compared with those screened annually. There was also no indication that annual screening would benefit women with dense breasts. However, for women in their 40s, those who received biennial screening were more likely to have late-stage disease when they were diagnosed with breast cancer than were those who received annual mammograms (28% versus 21%).

"In summary, we found little evidence that indicates that women who undergo mammography screening every 2 years have an increased risk of late-stage breast cancer compared with women who undergo annual screening, except for women in their 40s," the authors write. "Our results may be useful for policy makers and for statistical modelers of mammography screening who seek to understand the costs and benefits of screening annually versus every 2 years."
 

- December 15 issue of the Journal of the National Cancer Institute
 

Visit the Journal online at http://jncicancerspectrum.oupjournals.org/.

 
Subscribe to Breast Newsletter
E-mail Address:

 



Related Breast News

Breast cancer chemotherapy may deterioration in cognitive function
Elderly Breast Cancer Patients May Be Under-Diagnosed And Under-Treated
Tissue Geometry Plays Crucial Role in Breast Cell Invasion
Ethnic variations in hormone levels may cause differences in breast cancer risk
Researchers set benchmarks for screening mammography
Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at All Risk Levels
Physical activity improves survival in breast cancer patients
Pedigree assessment tool correctly identifies women with higher risk of breast cancer
MRI more accurately determines cancer spread into breast ducts
Core needle biopsy gives an accurate picture of gene expression


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us